Celldex Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Celldex Therapeutics Inc
TickerCLDX
CIK #0000744218
CUSIP15117B202
SectorLife Sciences - In Vitro & In Vivo Diagnostic Substances
Address119 Fourth Ave, Needham, MA 02494
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Celldex Therapeutics Inc 2016-11-29 62.5 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0000744218] 10-K
[0000744218] 10-Q
[0000744218] 3
[0000744218] 4
[0000744218] 8-K
[0000744218] D
[0000744218] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
State Street Corp Celldex Therapeutics Inc [2026-05-12] 0.0
Vanguard Capital Management LLC Celldex Therapeutics Inc [2026-04-29] 0.0
State Street Corp Celldex Therapeutics Inc [2026-02-09] 0.0
Bellevue Group AG Celldex Therapeutics Inc [2025-11-14] 0.0
Point72 Asset Management LP Celldex Therapeutics Inc [2025-07-10] 0.0
Commodore Capital LP Celldex Therapeutics Inc [2025-04-10] 0.0
Price T Rowe Associates Inc /MD/ Celldex Therapeutics Inc [2025-02-14] 0.0
Eventide Asset Management LLC Celldex Therapeutics Inc [2024-02-14] 6.64
Kynam Capital Management LP Celldex Therapeutics Inc [2024-02-14] 5.5
Polar Capital Holdings PLC Celldex Therapeutics Inc [2024-02-13] 5.73
Point72 Asset Management LP Celldex Therapeutics Inc [2023-11-20] 6.6
Wellington Management Group LLP Celldex Therapeutics Inc [2023-02-06] 0.87
Viking Global Investors LP Celldex Therapeutics Inc [2022-06-10] 5.1
State Street Corp Celldex Therapeutics Inc [2022-02-10] 5.07
Vanguard Group Inc Celldex Therapeutics Inc [2022-02-09] 5.17
BlackRock Inc Celldex Therapeutics Inc [2022-02-04] 6.6
FMR LLC Celldex Therapeutics Inc [2021-10-12] 0.0
Cowen Financial Products LLC Celldex Therapeutics Inc [2021-02-25] 5.0939
Redmile Group LLC Celldex Therapeutics Inc [2021-02-16] 6.9
Logos Global Management LP Celldex Therapeutics Inc [2020-10-22] 4.3
Adage Capital Partners GP LLC Celldex Therapeutics Inc [2020-07-24] 5.01
Biotechnology Value Fund L P Celldex Therapeutics Inc [2020-06-26] 3.8
RTW Investments LP Celldex Therapeutics Inc [2020-06-19] 0.95
Ikarian Capital LLC Celldex Therapeutics Inc [2020-06-18] 7.1
Renaissance Technologies LLC Celldex Therapeutics Inc [2020-02-12] 6.91
Columbia Wanger Asset Management LLC Celldex Therapeutics Inc [2017-02-10] 5.1
KLP Enterprises LLC Celldex Therapeutics Inc [2016-12-09] 5.7
State Street Corp Celldex Therapeutics Inc [2016-04-08] 8.67
First Trust Portfolios LP Celldex Therapeutics Inc [2016-01-27] 7.53
Vanguard Group Inc Celldex Therapeutics Inc [2014-02-12] 5.59
Franklin Resources Inc Celldex Therapeutics Inc [2014-02-11] 0.0
FMR LLC Celldex Therapeutics Inc [2013-09-10] 0.0
SAC Capital Advisors LP Celldex Therapeutics Inc [2013-04-22] 4.9
SAC Capital Advisors LP Celldex Therapeutics Inc [2013-04-05] 4.9
Prudential Financial Inc Celldex Therapeutics Inc [2013-02-13] 5.9
Jennison Associates LLC Celldex Therapeutics Inc [2013-02-11] 5.7
BlackRock Inc Celldex Therapeutics Inc [2013-01-30] 8.65
Ridgeback Capital Investments LP Celldex Therapeutics Inc [2012-12-28] 6.1
Form 3/4/5 Filer 2011 - 2026
Celldex Therapeutics Inc
Brownlie Keith L
Lawver Teri L
Keler Tibor
Marucci Anthony S
Jimenez Freddy A
Conrad Herbert J
Torres Denice
Heath-Chiozzi Margo
Cavanaugh Sarah
Martin Samuel Bates
Marino James J
Penner Harry Jr
Jain Rita
Crowley Elizabeth
Young Diane C
Pepin Ronald
Neil Garry Arthur
Cohen Cheryl
Wright Richard M
Lipton Karen Shoos
McMahon Gerald PhD
Ellberger Larry
Davis Thomas Andrew
LaVallee Theresa
Catlin Avery W
van den Broek Richard
Elston George
Shannon Timothy M
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Martin Samuel Bates
Common Stock
2026-01-02 Option exercise 4,817 $10.38 50,000
Martin Samuel Bates
Incentive Stock Option (Right to Buy) · derivative
2026-01-02 Option exercise 4,817 $0.00
Pepin Ronald
Incentive Stock Option (right to buy) · derivative
2025-12-15 Option exercise 8,333 $0.00
Pepin Ronald
Common Stock
2025-12-15 Option exercise 11,000 $2.78 30,580
Pepin Ronald
Common Stock
2025-12-15 Option exercise 8,333 $9.02 75,164
Pepin Ronald
Incentive Stock Option (right to buy) · derivative
2025-12-15 Option exercise 11,000 $0.00
Jimenez Freddy A
Common Stock
2025-12-04 Sell 4,166 $29.10 121,231
Wright Richard M
Incentive Stock Option · derivative
2025-11-13 Option exercise 6,876 $0.00
Wright Richard M
Common Stock
2025-11-13 Option exercise 6,876 $9.02 62,022
Wright Richard M
Incentive Stock Option · derivative
2025-11-13 Option exercise 26,672 $0.00
Wright Richard M
Common Stock
2025-11-13 Option exercise 26,672 $10.38 276,855
Wright Richard M
Common Stock
2025-11-13 Sell 49,298 $24.00 1,183,152
Wright Richard M
Incentive Stock Option · derivative
2025-11-13 Option exercise 15,750 $0.00
Wright Richard M
Common Stock
2025-11-13 Option exercise 15,750 $22.48 354,060
Lawver Teri L
ISO (right to buy) · derivative
2025-11-10 Grant 100,000 $0.00
Jimenez Freddy A
Common Stock
2025-08-13 Sell 430 $25.42 10,931
Jimenez Freddy A
Common Stock
2025-08-13 Sell 341 $23.95 8,167
Martin Samuel Bates
Incentive Stock Option (right to buy) · derivative
2025-06-05 Grant 81,000 $0.00
Neil Garry Arthur
Non-Qualified Stock Option (right to buy) · derivative
2025-06-05 Grant 16,500 $0.00
Cavanaugh Sarah
Incentive Stock Option (right to buy) · derivative
2025-06-05 Grant 78,000 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 231 71,230,318
2025-12-31 189 71,584,826
2025-09-30 189 68,756,350
2025-06-30 185 69,043,356
2025-03-31 175 70,528,783
2024-12-31 183 69,890,298
2024-09-30 185 69,806,013
2024-06-30 185 66,859,452
2024-03-31 201 67,428,128
2023-12-31 168 62,328,220
2023-09-30 150 51,143,237
2023-06-30 153 49,927,716
Form 13F Holdings
Firm Period DFND Voting Shares
Assenagon Asset Management SA [2026-06-30] SOLE 788,696 788,696
Mirador Capital Partners LP [2026-06-30] SOLE 181,054 181,054
Simplify Asset Management Inc [2026-06-30] SOLE 53,134 53,134
Hennion & Walsh Asset Management Inc [2026-06-30] SOLE 47,113 47,113
Y-Intercept Hong Kong Ltd [2026-06-30] SOLE 32,257 32,257
Diversified Trust Co [2026-06-30] SOLE 0 31,330
Apella Capital LLC [2026-06-30] SOLE 0 26,658
PSP Research LLC [2026-06-30] SOLE 0 13,000
Curated Wealth Partners LLC [2026-06-30] OTR 0 10,000
Versant Capital Management Inc [2026-06-30] SOLE 689 689
Gamma Investing LLC [2026-06-30] DFND 356 356
IFP Advisors LLC [2026-06-30] SOLE 259 259
Farther Finance Advisors LLC [2026-06-30] SOLE 0 216
True Wealth Design LLC [2026-06-30] SOLE 0 40
Handelsbanken Fonder AB [2026-06-30] SOLE 0 27
MassMutual Private Wealth & Trust FSB [2026-06-30] SOLE 18 18
Fortitude Family Office LLC [2026-06-30] SOLE 16 16
GHP Investment Advisors Inc [2026-06-30] SOLE 0 3
Capital Advisors Ltd LLC [2026-06-30] SOLE 0 1
Hughes Financial Services LLC [2026-06-30] SOLE 1 1
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com